Historical record - last NADAC effective date: 12/21/2016
Product Information
ISONIAZID 50 MG/5 ML SOLUTION is a generic product labeled by CMP Pharma, Inc., priced at $0.3100 per ML under NDC 46287000901. Its NADAC has been published 211 times since Nov 28, 2013.
FDA first approved this application on Nov 10, 1983. Its Orange Book therapeutic-equivalence code is AA.
The Low Outlier badge above means this manufacturer's average price in the isoniazid market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
50 mg/5mL
Manufacturer
CMP Pharma, Inc.NDC
46287000901
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL
Effective Date
12/21/2016
Active Ingredients
ISONIAZIDApproval Type
Generic (ANDA)
FDA Application
ANDA088235FDA Approved
11/10/1983
TE Code
AA
On Market Since
11/11/1983
Pharmacological Classes
Price Statistics
The NADAC for ISONIAZID 50 MG/5 ML SOLUTION has been published 211 times since Nov 28, 2013, and over the history we have for it it has risen 250.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3100 per ML |
|---|---|
| All-time high | $0.3100 (Dec 6, 2017) |
| All-time low | $0.0884 (Nov 28, 2013) |
| Median price | $0.2552 |
| Average price | $0.2235 |
| Largest weekly change | +57.0% (Feb 18, 2015) |
| Weeks tracked | 211 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+250.8%
Last surveyed Dec 6, 2017 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the isoniazid market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
CMP Pharma, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
isoniazid market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Antimycobacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ISONIAZID 50 MG/5 ML SOLUTION?
The current National Average Drug Acquisition Cost (NADAC) for ISONIAZID 50 MG/5 ML SOLUTION, manufactured by CMP Pharma, Inc., is $0.3100 per ML (NDC 46287000901), effective Dec 6, 2017.
How has the price of ISONIAZID 50 MG/5 ML SOLUTION changed over time?
Over the history we have for it, the NADAC for ISONIAZID 50 MG/5 ML SOLUTION has risen 250.8%. It has been tracked across 211 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for ISONIAZID 50 MG/5 ML SOLUTION?
Since Nov 28, 2013, the NADAC for ISONIAZID 50 MG/5 ML SOLUTION has ranged from a low of $0.0884 (Nov 28, 2013) to a high of $0.3100 (Dec 6, 2017), with a median of $0.2552 per ML.
Are there cheaper alternatives to ISONIAZID 50 MG/5 ML SOLUTION?
No other NADAC-published product currently shares the active ingredient and strength of ISONIAZID 50 MG/5 ML SOLUTION in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ISONIAZID 50 MG/5 ML SOLUTION?
ISONIAZID 50 MG/5 ML SOLUTION (NDC 46287000901) is labeled by CMP Pharma, Inc., and CMS classifies it as a generic product.